Mode
Text Size
Log in / Sign up

Surgical excision in dromedary camels yields 83.70% recovery with 16.30% complications across cutaneous and subcutaneous massesMost Camel Skin Lumps Don’t Turn Cancerous

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that surgical excision in dromedary camels shows 83.70% recovery with manageable complications in this observational cohort.

This cohort study included 92 confirmed cases of cutaneous and subcutaneous masses in dromedary camels (Camelus dromedarius) from Riyadh, Al Qassim, and Eastern provinces of Saudi Arabia. The primary intervention was surgical excision, with secondary outcomes including lesion classification, anatomical location, and demographic distributions. Non-neoplastic lesions were the most frequent outcome at 60.87%, followed by neoplastic lesions at 39.13% of cases. Among neoplastic components, fibromas represented 23.91% and papillomas 10.87%.

Anatomically, hindlimb lesions were the most common site at 26.09%, followed by head lesions at 17.39%. Higher lesion frequencies were observed in camels aged 5–10 years (75%) and females (64.13%). The Wadeh breed was the most represented at 56.52%. Safety data indicated that adverse events included edema, hemorrhage, infection, or recurrence, occurring in 16.30% of cases (15/92). Complete primary recovery was achieved in 83.70% of cases (77/92). All complications were successfully managed.

The study notes that comprehensive clinicopathological data regarding prevalence, classification, and clinical outcomes remain limited. Consequently, these results provide clinicians with valuable insights into clinical frequency and diagnostic characteristics but do not establish causal treatment benefits. The data supports improved clinical decision-making by establishing a baseline for classifying lesions in this population.

A camel limps into a veterinary clinic in Saudi Arabia. The owner points to a lump on its leg. Is it dangerous? Should it be removed? For years, vets had to guess. Now, they don’t have to.

Skin lumps in camels are common. But until now, no one knew how many were harmless—and how many could turn serious. In rural and desert communities, camels are more than animals. They’re transport, milk, meat, and wealth. A sick camel means lost income, lost food, lost mobility.

For decades, vets treated each lump as a mystery. Some removed them out of caution. Others waited, risking infection or spread. There was no clear pattern—until now.

Most lumps aren’t cancer

That changes with a new study of 92 camels seen at clinics across Saudi Arabia. For the first time, researchers have mapped what kinds of lumps show up, where, and what happens after treatment.

The surprise? Over 60% of lumps were not cancerous. These were mostly granulomas—knots of inflamed tissue—or old abscesses, like scars from past infections. They don’t spread. They don’t grow out of control. But they can hurt, swell, or get infected.

Only 39% were tumors. And even most of those were benign—like fibromas (fibrous tissue growths) and papillomas (wart-like bumps). Very few showed signs of being aggressive or life-threatening.

This is a big deal. It means vets can now tell owners: This lump is likely safe. We can watch it—or remove it if it’s causing trouble.

Lumps show up in predictable places

The study found that lumps most often appear on the hind legs and head. Camels use their legs constantly—walking long distances, kicking, brushing against thorny plants. The head gets bumped during feeding or fighting. These areas take the most wear and tear.

Most affected camels were between 5 and 10 years old—prime working age. Females were more likely to have lumps than males. And one breed, the Wadeh camel, showed up most often in the data.

Why? It’s not genetics. Researchers believe it’s exposure. Wadeh camels are widely raised in the study regions. More animals mean more chances to see lumps.

Surgery works—and works well

When vets removed the lumps, 84% of camels healed completely the first time. That’s a strong success rate—especially in remote areas where follow-up care is hard.

But there’s a catch.

About 16% had complications. Some had swelling. A few bled or got infections. A small number had the lump come back. But every single case was managed successfully—no deaths, no long-term harm.

This doesn’t mean this treatment is available yet.

Wait—available? These surgeries already happen. The real value isn’t the surgery itself. It’s the diagnosis. Now, vets can look at a lump and say: This looks like a granuloma. It’s not cancer. We can treat it this way.

Before, they might have panicked. Removed too much tissue. Or worse—ignored a dangerous lump, thinking it was harmless. Now, there’s a roadmap.

Think of it like a traffic jam in the body. Inflammation builds up—immune cells rush in, get stuck, form a knot. That’s a granuloma. It’s not a broken engine (cancer), just a backup. Surgery clears the road.

A tumor is different. It’s like a factory that won’t shut down—cells keep dividing nonstop. But even then, many camel tumors are like a factory making harmless products. They grow, but they don’t invade.

Most cases heal with one surgery

The study looked at camels brought to clinics—not random herds. So it reflects real-world care. All diagnoses were confirmed by tissue tests, the gold standard.

Camels came from three regions: Riyadh, Al Qassim, and the Eastern Province. Each had similar patterns. That suggests the findings aren’t flukes—they likely apply across camel populations in dry, hot climates.

Not all camels were included

The study didn’t look at very young or very old camels. Most lumps appeared in middle-aged animals, so younger ones may have different risks. Also, only camels with visible lumps were studied. Some internal tumors might have been missed.

And while surgery worked well, it’s not always easy. In remote areas, anesthesia, sterile tools, and trained staff can be scarce. A simple removal can become risky without the right setup.

Still, the results are clear: most lumps are treatable. And knowing what’s common helps clinics prepare—ordering the right supplies, training staff, advising owners.

What happens next? This study sets a baseline. Future research can track whether certain lumps become cancer over time. Or test if non-surgical treatments—like injections or antibiotics—can help avoid surgery in mild cases.

For now, vets have something powerful: data. Not guesses. Not tradition. Evidence.

That means fewer unnecessary surgeries. Faster recoveries. Healthier camels. And stronger support for the people who depend on them.

The next time a camel walks into a clinic with a lump, the vet won’t have to wonder. They’ll know what’s most likely—and what to do.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Cutaneous and subcutaneous masses are frequently encountered in dromedary camels. However, comprehensive clinicopathological data regarding their prevalence, classification, and clinical outcomes remain limited. This study aimed to describe the diagnostic characteristics and surgical outcomes of skin masses in a hospital-presented camel cohort. Between September 2023 and August 2024, a total of 213 dromedary camels were selected through purposive sampling based on the clinical presentation of various skin conditions across Riyadh, Al Qassim and Eastern provinces of Saudi Arabia. From this initial group, 92 cases of confirmed cutaneous or subcutaneous masses were included. Data on lesion type, anatomical location, age, sex, breed, and treatment outcome were collected and analyzed. Six types of skin masses were classified as neoplastic or non-neoplastic based on definitive histopathological biopsy features. Non-neoplastic lesions were the most frequent (60.87%), with granulomas and chronic abscesses predominating. Neoplastic lesions accounted for 39.13% of cases, primarily consisting of fibromas (23.91%) and papillomas (10.87%). The most common anatomical sites for lesion occurrence were the hindlimbs (26.09%) and the head (17.39%). A higher frequency of lesions was observed in camels aged 5–10 years (75%) and in females (64.13%). Among breeds, Wadeh camels (56.52%) were most represented. Surgical excision resulted in complete primary recovery in 83.70% (77/92) of cases. While 16.30% (15/92) experienced postoperative complications, including edema, hemorrhage, infection, or recurrence, all were successfully managed. This study provides clinicians with valuable insights into the clinical frequency, diagnostic characteristics, and treatment outcomes of cutaneous and subcutaneous masses in dromedary camels. These findings establish a clinical baseline for classifying such lesions, supporting improved clinical decision-making and providing a foundation for future research in camelid medicine.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.